Keywords
Psoriasis
treatment
biologic therapies
skin
immune system
treatment
biologic therapies
skin
immune system
How to Cite
Ulacia Epelde, L., Lizardi Mutuberria, A., Garcia de Andoin Barandiara, M. J., Umerez Igartua, M., Landa Alberdi, J., Leunda Eizmendi, L., Urretavizcaya Anton, M., Beristain Aramendi, I., & Ercilla Liceaga, M. (2023). Psoriasis, what is it and how can we treat it?. Osagaiz: Osasun-Zientzien Aldizkaria, 7(1). Retrieved from https://aldizkariak.ueu.eus/index.php/osagaiz/article/view/492
Abstract
Psoriasis is an immune-mediated chronic recurrent disease with mainly cutaneous manifestations. Although it manifests itself in a mild way in most patients, it can cause physical, social, or psychological disability in some people, having a significant impact on the quality of their lives. There have been important advances in the treatment of psoriasis in the last years, specially in the field of biologic therapies. New highly effective treatments targeting different intermediaries involved on the onset of psoriasis have been developed, but psoriasis still remains an incurable disease.
Most read articles by the same author(s)
- Mikel Urretabizkaia, Pilar Bachiller, Josune Garcia de Andoin, Koro Andueza, Laura Basterretxea, Miren Ercilla, Maitane Umenez, Larraitz Leunda, Aitziber Lizardi, June Landa Alberdi, GarbiƱe Lizeaga, Online pharmaceutical care in oncology setting: developing new pilot models , Osagaiz: osasun-zientzien aldizkaria: Vol. 4 No. 1 (2020)
- Idoia Beristain Aramendi, Miren Ercilla Liceaga, Leire Ulacia, Mikel Urretavizcaya, Aitziber Lizardi, Miren Josune Garcia de Andoin, Maitane Umerez, June Landa, Larraitz Leunda, Collaboration between pharmacist and doctor to ensure the efficacy and safe-ty of treatments in patients with HIV , Osagaiz: osasun-zientzien aldizkaria: Vol. 8 No. 1 (2024): Osagaiz: health sciences magazine
- Josune Garcia de Andoin Barandiaran, Maitane Umerez Igartua, Miren Ercilla Liceaga, June Landa Alberdi, Larraitz Leunda Eizmendi, Mikel Urretavizcaya Anton, Aitziber Lizardi Mutuberria, What can we do when the pharmaceutical-provision of the public health system doesn't include the medications for our patient clinical needs? , Osagaiz: osasun-zientzien aldizkaria: Vol. 5 No. 1 (2021)
- June Landa Alberdi, Larraitz Leunda Eizmendi, Miren Ercilla Liceaga, Maitane Umerez Igartua, Aitziber Lizardi Mutuberria, Miren Josune Garcia de Andoin Barandiaran, Mikel Urretavizcaya Anton, Amyotrophic lateral sclerosis , Osagaiz: osasun-zientzien aldizkaria: Vol. 3 No. 2 (2019)
- Maitane Umerez Igartua, Larraitz Leunda Eizmendi, June Landa Alberdi, Miren Ercilla Liceaga, Mikel Urretavizcaya Anton, Aitziber Lizardi Mutuberria, Josune Garcia de Andoin Barandiaran, Pharmaceutical-provision, which medicines will be paid and to what price? , Osagaiz: osasun-zientzien aldizkaria: Vol. 4 No. 2 (2020)
- Aitziber Lizardi Mutuberria, Miren Josune Garcia de Andoin Barandiaran, Maitane Umerez Igartua, Miren Ercilla Liceaga, June Landa Alberdi, Larraitz Leunda Eizmendi, Mikel Urretavizcaya Anton, Undesirable effects of antineoplastic agents: which are they and how are they handled? , Osagaiz: osasun-zientzien aldizkaria: Vol. 5 No. 2 (2021)
- June Landa Alberdi, Larraitz Leunda Eizmendi, Miren Ercilla Liceaga, Maitane Umerez Igartua, Aitziber Lizardi Mutuberria, Miren Josune Garcia de Andoin Barandiaran, Mikel Urretavizcaya Anton, Idoia Beristain Aramendi, Leire Ulacia Epelde, Management of anemia and febrile neutropenia in patients treated for malignancy , Osagaiz: osasun-zientzien aldizkaria: Vol. 8 No. 1 (2024): Osagaiz: health sciences magazine